Shares of Pluristem Therapeutics Inc. (PSTI) rose over 11% on Wednesday, following positive data from the company’s preclinical studies of PLX-PAD cells in the treatment of Duchenne muscular dystrophy.
Forex – financial instrument.Forex news
Shares of Pluristem Therapeutics Inc. (PSTI) rose over 11% on Wednesday, following positive data from the company’s preclinical studies of PLX-PAD cells in the treatment of Duchenne muscular dystrophy.